Protecting against HPV vaccine misinformation with current and future caregivers in South Africa

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202605782745913

Enrollment

2500

Registered

2026-05-29

Start date

2026-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papillomavirus

Interventions

Active Comparator Control

Enhanced inoculation message

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults aged 18-49 years [this includes current and prospective caregivers residing in South Africa] Willing and able to provide consent Able to read and understand English

Exclusion criteria

Exclusion criteria: Unwilling or unable to provide consent for study participation

Design outcomes

Primary

Measure	Time frame
HPV vaccine acceptance and intention, at the end of the baseline assessment Acceptance and intention to get the HPV vaccine, measured after inoculation intervention and misinformation exposure. Intentions will be measured on a 0-10 scale.	—

Secondary

Measure	Time frame
Caregivers/prospective caregivers’ intention to get the HPV vaccine for their children 2-6 weeks following the exposure, believability and persuasiveness of misinformation, interest in sharing misinformation, and motivational threat associated with misinformation. ;Subgroup effects by relevant sociodemographic and behavioural factors.	—

Countries

South Africa

Contacts

Public ContactCandice Chetty Makkan

Principal Researcher

cchetty@heroza.org27832892181

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026